Time to clozapine response in a standardized trial

American Journal of Psychiatry

Volumn 154, Issue 9, 1997, Pages 1243-1247

  Conley, Robert R ^a,b   Carpenter Jr , William T ^a   Tamminga, Carol A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030863262     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.9.1243     Document Type: Article

References (24)

1. Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Arch Gen Psychiatry 1968; 18:482-495
2. Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L: Clozapine eligibility among state hospital patients. Schizophr Bull 1996; 22:15-25
3. Baldessarini RJ, Frankenburg FR: Clozapine: a novel antipsychotic agent. N Engl J Med 1991; 324:746-754
4. Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B: Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991; 17:247-261
5. Carpenter WT Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA: Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995; 152:827-832
6. Meltzer HY: Clozapine: is another view valid? (editorial). Am J Psychiatry 1995; 152:821-825
7. Lindstrom LH: The effect of long term treatment of clozapine in schizophrenia: a retrospective study of 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 1988; 77: 524-529
8. Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
9. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J: A prospective study of clozapine in treatment-resistant schizophrenic patients, I: preliminary report. Psychopharmacology (Berl) 1989;99(suppl):S68-S72
10. Mattes JA: Clozapine for refractory schizophrenia: an open study of 14 patients treated up to two years. J Clin Psychiatry 1989; 50:389-391
11. Owen RR, Beake BJ, Marby D, Dessain EC, Cole JO: Response to clozapine in chronic psychotic patients. Psychopharmacol Bull 1989; 25:253-256
12. Middleton S, Huntsberger J, Haver J: Delayed response: Darla M, in Clozapine: Compendium of Selected Readings. Edited by Yesavage J. East Hanover, NJ, Sandoz Pharmaceuticals Corp, 1992
13. Wilson WH: Time required for initial improvement during clozapine treatment of refractory schizophrenia. Am J Psychiatry 1996; 153:951-952
14. Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM: Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 1994; 151:1744-1752
15. Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbrook R, Tuason V, Klerman G: The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 1987; 7:377-384
16. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version 1.0 (SCID-P). Washington, DC, American Psychiatric Press, 1990
17. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
18. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, Md, US Department of Health, Education, and Welfare, 1976, pp 217-222
19. Kleibaum D: Survival Analysis. New York, Springer-Verlag, 1996
20. Ratey JJ, Leveroni C, Kilmer D, Gutheil C, Swartz B: The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 1993; 54:219-223
21. Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH: Clinical and biologic response to clozapine in patients with schizophrenia. Arch Gen Psychiatry 1992; 49:345-353
22. Van Putten T, Marder SR, Mintz J, Poland RE: Haloperidol plasma levels and clinical response: a therapeutic window relationship. Psychopharmacol Bull 1988; 24:172-175
23. Zito JM, Volavka J, Craig TJ, Czobor P, Banks S, Vitrai J: Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia. Ann Pharmacother 1993; 27:1262-1269
24. Wilson WH: Clinical review of clozapine treatment in a state hospital. Hosp Community Psychiatry 1992; 43:700-703